YY2 and neoplasm: In contrast, the induction of excessive CIN in those cells by YY2 overexpression sensitizes them to DNA damage‐inducing agents, suggesting a novel anti‐tumor therapeutic approach by combining SAC activator and DNA damage‐inducing agents.